Aroa Financial Statements From 2010 to 2025

Stocks . Australia . 
Stock . Aroa Biosurgery
ARX Stock   0.75  0.02  2.60%   
Aroa Biosurgery financial statements provide useful quarterly and yearly information to potential Aroa Biosurgery investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aroa Biosurgery financial statements helps investors assess Aroa Biosurgery's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aroa Biosurgery's valuation are summarized below:
Gross Profit
30.3 M
Profit Margin
(0.15)
Market Capitalization
258.7 M
Enterprise Value Revenue
3.484
Revenue
69.1 M
There are currently eighty-six fundamental signals for Aroa Biosurgery that can be evaluated and compared over time across rivals. All traders should validate Aroa Biosurgery's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Aroa Biosurgery Total Revenue

76.5 Million

Check Aroa Biosurgery financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aroa Biosurgery's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 652.9 K or Total Revenue of 76.5 M, as well as many indicators such as . Aroa financial statements analysis is a perfect complement when working with Aroa Biosurgery Valuation or Volatility modules.
  
This module can also supplement various Aroa Biosurgery Technical models . Check out the analysis of Aroa Biosurgery Correlation against competitors.

Aroa Biosurgery Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets123 M117.2 M51.7 M
Slightly volatile
Other Current Liabilities5 M5.6 M3.2 M
Slightly volatile
Total Current Liabilities8.1 M7.9 M5.2 M
Slightly volatile
Total Stockholder Equity105.1 M100.1 M41.1 M
Slightly volatile
Other Liabilities140.2 K147.6 K728.2 K
Very volatile
Accounts Payable853.8 K1.4 M781.5 K
Slightly volatile
Cash8.2 M12.2 M9.5 M
Slightly volatile
Other Assets0.860.988.7 K
Slightly volatile
Net Receivables29.1 M27.7 M8.3 M
Slightly volatile
Short Term Investments20.7 M19.7 M8.9 M
Slightly volatile
Other Current Assets3.6 M3.7 M1.9 M
Slightly volatile
Total Liabilities13.8 M13.3 M10.1 M
Slightly volatile
Common Stock108.9 M154.8 M114 M
Very volatile
Property Plant Equipment10.5 M18.6 M9.5 M
Slightly volatile
Total Current Assets76.5 M72.8 M31 M
Slightly volatile
Intangible Assets12.6 M14.9 M10.6 M
Slightly volatile
Short and Long Term Debt Total8.2 M7.8 M4.9 M
Slightly volatile
Property Plant And Equipment Net13.4 M23.4 M9.8 M
Slightly volatile
Non Current Assets Total30.1 M44.3 M19 M
Slightly volatile
Cash And Short Term Investments32.7 M31.9 M18.7 M
Slightly volatile
Good Will4.2 M4.6 M5.2 M
Slightly volatile
Common Stock Shares Outstanding350.4 M395.4 M317.2 M
Slightly volatile
Long Term Debt Total4.1 M7.5 M3.1 M
Slightly volatile
Liabilities And Stockholders Equity82.3 M117.2 M51.4 M
Slightly volatile
Non Current Liabilities Total7.5 M5.5 M9.4 M
Slightly volatile
Inventory9 M8.5 M3.5 M
Slightly volatile
Accumulated Other Comprehensive Income11.4 M10.9 M3.3 M
Slightly volatile
Short Term Debt1 M1.1 M1 M
Slightly volatile
Capital Lease Obligations5.9 M7.8 M3.7 M
Slightly volatile
Net Invested Capital91.1 M100.2 M80.2 M
Slightly volatile
Property Plant And Equipment Gross23 M35.1 M15 M
Slightly volatile
Short and Long Term Debt5.5 M10.5 M3.8 M
Slightly volatile
Capital Stock130 M154.9 M107.8 M
Slightly volatile
Net Working Capital59 M62.8 M52 M
Slightly volatile
Deferred Long Term Liabilities1.1 M1.2 M1.3 M
Slightly volatile

Aroa Biosurgery Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative652.9 K687.2 K8.8 M
Slightly volatile
Cost Of Revenue11.2 M10.6 M4.9 M
Slightly volatile
Total Operating Expenses65.3 M62.2 M22.7 M
Slightly volatile
Interest Income1.1 M1.9 M653.8 K
Slightly volatile
Depreciation And Amortization2.9 M4.6 M1.9 M
Slightly volatile
Other Operating Expenses44.6 M84.1 M31 M
Slightly volatile
Research Development6.8 M9.8 M5 M
Slightly volatile
Selling And Marketing Expenses41.3 M65.6 M28.6 M
Slightly volatile
Reconciled Depreciation3.7 M4.6 M3.1 M
Slightly volatile

Aroa Biosurgery Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures5 M5.8 M2.4 M
Slightly volatile
Depreciation4.9 M4.7 M1.8 M
Slightly volatile
End Period Cash Flow7.2 M12.2 M4.9 M
Slightly volatile
Begin Period Cash Flow6.5 M10.1 M4.1 M
Slightly volatile
Other Non Cash Items5.8 M8.3 M5.3 M
Slightly volatile
Dividends Paid0.06840.07212.5 M
Slightly volatile
Issuance Of Capital Stock153.7 K161.8 K25 M
Slightly volatile

Aroa Fundamental Market Drivers

Forward Price Earnings39.3701
Cash And Short Term Investments27.7 M

About Aroa Biosurgery Financial Statements

Aroa Biosurgery shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aroa Biosurgery investors may analyze each financial statement separately, they are all interrelated. The changes in Aroa Biosurgery's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aroa Biosurgery's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue 1.80  1.71 
Total Revenue72.9 M76.5 M
Cost Of Revenue10.6 M11.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aroa Stock Analysis

When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY